Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Tenascin and Fibronectin Expression in Carcinoma Ex Pleomorphic Adenoma

Tenascin and Fibronectin Expression in Carcinoma Ex Pleomorphic Adenoma RESEARCH ARTICLE Tenascin and Fibronectin Expression in Carcinoma Ex Pleomorphic Adenoma Vera Cavalcanti de Arau´jo, DDS, PhD,* Cristiane Furuse, DDS, PhD,* Patricia Ramos Cury, DDS, PhD,w Albina Altemani, MD, PhD,z Venaˆncio Avancini Ferreira Alves, MD, PhD,y and Ney Soares de Arau´jo, DDS, PhDJ arcinoma ex pleomorphic adenoma (CXPA), a rare Abstract: This study was conducted to analyze the participation Cmalignant salivary gland tumor, is an important of tenascin and fibronectin, components of the extracellular model to study the complex mechanism of tumor matrix, in different types of carcinoma ex pleomorphic adenoma malignization and progression. Our group has studied (CXPA). Seventeen cases of CXPA, classified according to the several aspects of this lesion such as cytoskeleton, presence of epithelial and myoepithelial cells and the degree of adhesion molecules, and proteins involved in cell cycle. invasion—intracapsular, minimally, and frankly invasive carci- Recently, we demonstrated by immunohistochemistry noma—were immunohistochemically labeled for tenascin and that CXPA is composed of tumors either with only fibronectin. Normal salivary gland included in the specimens epithelium differentiation or with epithelium and myoe- showed tenascin only around the excretory duct, and fibronectin pithelium. These salivary gland tumors were classified as slightly expressed all over the stroma of the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Tenascin and Fibronectin Expression in Carcinoma Ex Pleomorphic Adenoma

Loading next page...
 
/lp/wolters-kluwer-health/tenascin-and-fibronectin-expression-in-carcinoma-ex-pleomorphic-lZtDgvn01n

References (39)

ISSN
1541-2016
DOI
10.1097/PAI.0b013e31802eff1c
pmid
18091320
Publisher site
See Article on Publisher Site

Abstract

RESEARCH ARTICLE Tenascin and Fibronectin Expression in Carcinoma Ex Pleomorphic Adenoma Vera Cavalcanti de Arau´jo, DDS, PhD,* Cristiane Furuse, DDS, PhD,* Patricia Ramos Cury, DDS, PhD,w Albina Altemani, MD, PhD,z Venaˆncio Avancini Ferreira Alves, MD, PhD,y and Ney Soares de Arau´jo, DDS, PhDJ arcinoma ex pleomorphic adenoma (CXPA), a rare Abstract: This study was conducted to analyze the participation Cmalignant salivary gland tumor, is an important of tenascin and fibronectin, components of the extracellular model to study the complex mechanism of tumor matrix, in different types of carcinoma ex pleomorphic adenoma malignization and progression. Our group has studied (CXPA). Seventeen cases of CXPA, classified according to the several aspects of this lesion such as cytoskeleton, presence of epithelial and myoepithelial cells and the degree of adhesion molecules, and proteins involved in cell cycle. invasion—intracapsular, minimally, and frankly invasive carci- Recently, we demonstrated by immunohistochemistry noma—were immunohistochemically labeled for tenascin and that CXPA is composed of tumors either with only fibronectin. Normal salivary gland included in the specimens epithelium differentiation or with epithelium and myoe- showed tenascin only around the excretory duct, and fibronectin pithelium. These salivary gland tumors were classified as slightly expressed all over the stroma of the

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Jan 1, 2008

There are no references for this article.